Functional expression and localization of P‐glycoprotein at the blood brain barrier

Until recently, the blood‐brain barrier was viewed as a static lipid membrane barrier. Physical attributes of the cerebral endothelial cells such as the presence of tight junctions, paucity of vesicles or caveolae, and high electrical resistance were believed to be the primary components that provide the membrane selectivity of the blood‐brain barrier to a variety of circulating compounds from the periphery. However, results from molecular biology, immunocytochemistry, biochemistry, and transport studies show that the cerebral endothelial cells possess an asymmetrical array of metabolic enzymes (i.e., alkaline phosphatase, cytochrome P450 enzymes, glutathione transferases) and energy‐dependent efflux transport proteins (i.e., P‐glycoprotein and Multidrug‐resistance proteins) that are instrumental to the barrier function. P‐glycoprotein, a membrane‐associated, energy‐dependent, efflux transporter, is expressed in brain parenchyma (i.e., astrocytes and microglia) as well as in blood‐brain and blood‐cerebrospinal fluid barriers. Its function along the blood‐brain barrier is believed to prevent the accumulation of potentially harmful compounds in the brain by actively removing them from the brain into the peripheral circulation. This is a brief review on the expression and activity of P‐glycoprotein at the blood‐brain barrier, which reports on the localization of the protein in rat brain capillaries in situ as well as in a well‐characterized in vitro model of the blood‐brain barrier, an immortalized rat brain endothelial cell line, the RBE4. Immunocytochemical analysis employing various P‐glycoprotein monoclonal antibodies, demonstrated the presence of the protein along the plasma membrane, in plasmalemmal vesicles and nuclear envelope of rat cerebral endothelial cells, both in situ and in vitro. Western blot analysis revealed a single band with a molecular weight of 170–180 kDa, a size previously reported for P‐glycoprotein, in RBE4 cells. In addition, results from functional studies show that the accumulation of the P‐glycoprotein substrate digoxin by RBE4 monolayer cells is significantly enhanced in the presence of standard P‐glycoprotein inhibitors (verapamil, cyclosporin A, PSC 833), protease inhibitors (saquinavir, ritonavir, indinavir), and the metabolic inhibitor, sodium azide. These results demonstrate the functional expression of P‐glycoprotein in the immortalized rat brain endothelial cell line, RBE4. Novel in situ and in vitro intracellular locations of P‐glycoprotein in cerebral endothelial cells have been identified suggesting that this transporter may play a significant role in the subcellular distribution of substrates in the brain. Microsc. Res. Tech. 57:365–380, 2002. © 2002 Wiley‐Liss, Inc.

[1]  M. Dehouck,et al.  Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture , 1989, Journal of neurochemistry.

[2]  T. Tsuruo,et al.  Specialized Localization of P‐Glycoprotein Recognized by MRK 16 Monoclonal Antibody in Endothelial Cells of the Brain and the Spinal Cord , 1990, Japanese journal of cancer research : Gann.

[3]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Sartorelli,et al.  Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Tsuruo,et al.  P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. , 1992, Life sciences.

[6]  W. Pardridge,et al.  Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate , 1995, Pharmaceutical Research.

[7]  J. Drewe,et al.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. , 2000, Molecular pharmacology.

[8]  T. Chambers,et al.  Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells. , 1992, Molecular pharmacology.

[9]  R. Béliveau,et al.  P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. , 1997, The Biochemical journal.

[10]  F. Oesch,et al.  Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system , 1991, Neuroscience.

[11]  M. Hart,et al.  Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. , 1989, The American journal of pathology.

[12]  I. Pastan,et al.  Expression of a multidrug-resistance gene in human tumors and tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Strosberg,et al.  Regulation of gamma‐glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells , 1994, Journal of cellular physiology.

[14]  W H Oldendorf,et al.  Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. , 1973, The American journal of physiology.

[15]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[16]  W. Mellado,et al.  Phosphorylation of the multidrug resistance associated glycoprotein. , 1987, Biochemistry.

[17]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[18]  U. Bickel,et al.  Brain Microvascular and Astrocyte Localization of P‐Glycoprotein , 1997, Journal of neurochemistry.

[19]  D. Back,et al.  Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. , 1999, AIDS.

[20]  P. Grammas,et al.  Primary culture of rat cerebral microvascular endothelial cells. Isolation, growth, and characterization. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[21]  F. Sharom The P-Glycoprotein Efflux Pump: How Does it Transport Drugs? , 1997, The Journal of Membrane Biology.

[22]  G. Siest,et al.  Localization of Drug‐Metabolizing Enzyme Activities to Blood‐Brain Interfaces and Circumventricular Organs , 1994, Journal of neurochemistry.

[23]  N. Yamamoto,et al.  Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors , 1999, Neuroscience Research.

[24]  J. Lawrenson,et al.  Cerebral and pial microvessels: differential expression of γ-glutamyl transpeptidase and alkaline phosphatase , 1999, Anatomy and Embryology.

[25]  I. Klatzo,et al.  Isolation of brain capillaries: a simplified technique , 1976, Brain Research.

[26]  B. Deurs,et al.  Cell junctions in the endothelia and connective tissue of the rat choroid plexus , 1979, The Anatomical record.

[27]  H. Galla,et al.  Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. , 2000, Brain research. Brain research protocols.

[28]  I. Pastan,et al.  Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Goldstein,et al.  Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. , 1978, Science.

[30]  M. Barrand,et al.  Comparisons of P‐glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta , 1995, FEBS letters.

[31]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[32]  T. Tsuruo,et al.  Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. , 1994, Biochemical pharmacology.

[33]  S. Rapoport,et al.  Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride , 1986, Journal of neurochemistry.

[34]  A. Schinkel,et al.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.

[35]  V. Ling,et al.  Functional intracellular P‐glycoprotein , 1998, International journal of cancer.

[36]  Y. Tanigawara,et al.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). , 1992, The Journal of pharmacology and experimental therapeutics.

[37]  G. Goldstein,et al.  Isolation of metabolically active capillaries from rat brain 1, 2 , 1975, Journal of neurochemistry.

[38]  C. Owman,et al.  A comparative study on the uptake and subsequent decarboxylation of monoamine precursors in cerebral microvessels. , 1979, Acta physiologica Scandinavica.

[39]  A. Strosberg,et al.  Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides , 1993, Journal of cellular physiology.

[40]  D. Gingras,et al.  P‐glycoprotein is localized in caveolae in resistant cells and in brain capillaries , 2000, FEBS letters.

[41]  J. Ford,et al.  Modulators of multidrug resistance. Preclinical studies. , 1995, Hematology/oncology clinics of North America.

[42]  D. Scherman,et al.  Functional Expression of P‐Glycoprotein in an Immortalised Cell Line of Rat Brain Endothelial Cells, RBE4 , 1996, Journal of neurochemistry.

[43]  J. Laplanche,et al.  Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes , 2000, Journal of neuroscience research.

[44]  B. Sikic,et al.  Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[45]  W. Pardridge,et al.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. , 1990, The Journal of biological chemistry.

[46]  R. Bendayan,et al.  Functional expression of P-glycoprotein in rat brain microglia. , 2001, The Journal of pharmacology and experimental therapeutics.

[47]  T. Tsuruo,et al.  Monoclonal antibodies specific for P-glycoprotein , 1997, Leukemia.

[48]  J. Greenwood,et al.  Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. , 1992, Journal of cell science.

[49]  C. Ringbom,et al.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[50]  K. Dziegielewska,et al.  BARRIER MECHANISMS IN THE BRAIN, I. ADULT BRAIN , 1999, Clinical and experimental pharmacology & physiology.

[51]  G R Wilkinson,et al.  Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[52]  I. Pastan,et al.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. Fiucci,et al.  Up-regulation of Caveolae and Caveolar Constituents in Multidrug-resistant Cancer Cells* , 1998, The Journal of Biological Chemistry.

[54]  A. Mooradian Potential mechanisms of the age-related changes in the blood-brain barrier , 1994, Neurobiology of Aging.

[55]  V. Ling Multidrug resistance: molecular mechanisms and clinical relevance , 1997, Cancer Chemotherapy and Pharmacology.

[56]  R. Monette,et al.  Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  M. Barrand,et al.  Multidrug Resistance‐Related Transport Proteins in Isolated Human Brain Microvessels and in Cells Cultured from These Isolates , 1998, Journal of neurochemistry.

[58]  J. Bourre,et al.  Lipid Synthesis by Rat Brain Microvessel Endothelial Cells in Tissue Culture , 1989, Journal of neuropathology and experimental neurology.

[59]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[60]  J. Berliner,et al.  Choline Uptake by Cerebral Capillary Endothelial Cells in Culture , 1990, Journal of neurochemistry.

[61]  P. Borst,et al.  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.

[62]  F. Baas,et al.  Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. , 1993, Pharmacology & therapeutics.

[63]  A. Schinkel,et al.  The physiological function of drug-transporting P-glycoproteins. , 1997, Seminars in cancer biology.

[64]  M. Melamed,et al.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M C Willingham,et al.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[66]  F. Sharom,et al.  Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.

[67]  K. Brendel,et al.  Isolated Brain Microvessels: A Purified, Metabolically Active Preparation from Bovine Cerebral Cortex , 1974, Science.

[68]  R. Bergmann,et al.  Mrp1 Multidrug Resistance‐Associated Protein and P‐Glycoprotein Expression in Rat Brain Microvessel Endothelial Cells , 1998, Journal of neurochemistry.

[69]  A. El Barbary,et al.  Glutathione S-transferase isoenzymes in rat brain neurons and glia , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  V. Ling,et al.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.

[71]  O. Fardel,et al.  Detection of P glycoprotein activity on normal and leukemic CD34+ cells. , 1993, Leukemia research.

[72]  I. Roninson,et al.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.

[73]  W. Oldendorf,et al.  Independent blood-brain barrier transport systems for nucleic acid precursors. , 1975, Biochimica et biophysica acta.

[74]  D. Kessel,et al.  On the characteristics of actinomycin D resistance in L5178Y cells. , 1970, Cancer research.

[75]  S. Heinemann,et al.  Ultrastructural changes accompanying the induced differentiation of clonal rat nerve and glia. , 1975, Neurobiology.

[76]  T. Terasaki,et al.  Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. , 2001, Biological & pharmaceutical bulletin.

[77]  D. Housman,et al.  The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues , 1989, Molecular and cellular biology.

[78]  P. Adamson,et al.  Dexamethasone Regulation of P‐Glycoprotein Activity in an Immortalized Rat Brain Endothelial Cell Line, GPNT , 1999, Journal of neurochemistry.

[79]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[80]  P. Gros,et al.  Phosphatidylcholine translocase: A physiological role for the mdr2 gene , 1994, Cell.

[81]  V. Ganapathy,et al.  Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4). , 2001, Biochimica et biophysica acta.

[82]  J. Huwyler,et al.  Characterization of transferrin receptor in an immortalized cell line of rat brain endothelial cells, RBE4. , 1999, Journal of receptor and signal transduction research.

[83]  R. Bendayan,et al.  Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs. , 1999, Canadian journal of physiology and pharmacology.

[84]  O. Fardel,et al.  The P-glycoprotein multidrug transporter. , 1996, General pharmacology.

[85]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[86]  F. Roux,et al.  Glucose transport in immortalized rat brain capillary endothelial cells in vitro: transport activity and GLUT1 expression. , 1997, Biochimica et biophysica acta.

[87]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[88]  H. Galla,et al.  The Susceptibility of Cerebral Endothelial Cells to Astroglial Induction of Blood‐Brain Barrier Enzymes Depends on Their Proliferative State , 1991, Journal of neurochemistry.

[89]  I. Roninson,et al.  Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. , 1992, Blood.

[90]  N. Cholet,et al.  Role of P‐170 glycoprotein in colchicine brain uptake , 1997, Journal of neuroscience research.

[91]  S. R. Harris,et al.  The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[92]  B. McEwen,et al.  Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.

[93]  W. Pardridge,et al.  P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries , 1999, Brain Research.

[94]  J. L. Biedler,et al.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. , 1970, Cancer research.

[95]  S. Bates,et al.  Differential modulation of P-glycoprotein transport by protein kinase inhibition. , 1993, Biochemistry.

[96]  V. Ling,et al.  Multidrug Resistance: Molecular Biology Clinical Relevance , 1989 .

[97]  T. Tsuruo,et al.  [Functional involvement of P-glycoprotein in blood-brain barrier]. , 1992, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[98]  L. Drewes,et al.  Cultured human and canine endothelial cells from brain microvessels , 1988, Brain Research Bulletin.

[99]  N. Baldini,et al.  P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. , 1999, Biology of the cell.

[100]  I. Romero,et al.  Transporting therapeutics across the blood-brain barrier. , 1996, Molecular medicine today.

[101]  V. Ling,et al.  P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteins , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[102]  F. Sharom,et al.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.

[103]  W. Pardridge,et al.  Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. , 1991, The Journal of pharmacology and experimental therapeutics.

[104]  N. Baldini,et al.  Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. , 1995, European journal of cell biology.

[105]  P. Bowman,et al.  Culture and characterization of microvascular endothelial cells derived from human brain. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[106]  S. Stenglein,et al.  Morphological and functional characterization of an in vitro blood–brain barrier model , 1997, Brain Research.

[107]  R. Bendayan,et al.  Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.

[108]  R. Broadwell Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal , 2004, Acta Neuropathologica.

[109]  B. Têtu,et al.  High levels of P-glycoprotein detected in isolated brain capillaries. , 1993, Biochimica et biophysica acta.

[110]  Thomas S. Reese,et al.  FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.

[111]  M. Obinata,et al.  mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a New in vitro BBB Model for Drug Targeting , 2000, Journal of drug targeting.